Position in RXRX
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$12,183,019
-$1,886,370 QoQ
Shares Held
3,968,411
+15.4% QoQ
Ownership
0.749%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2021
20 quarters on record
Voting authority
Sole 98%
Shared 2%
None 0%
Common Shares in RXRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026NORTHERN TRUST CORP holds $6,613,834,361 across 418 Biotechnology names. RXRX ranks #93 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,564,264 | $1,145,046,441 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
941,941 | $727,781,290 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
858,120 | $283,926,160 | |
| 4 | INSM |
INSMED Inc
|
1,294,000 | $211,594,876 | |
| 5 | RPRX |
Royalty Pharma plc
|
3,808,735 | $182,705,014 | |
| 6 | INCY |
Incyte Corp
|
1,849,726 | $174,096,208 | |
| 7 | MRNA |
Moderna, Inc.
|
2,952,041 | $149,963,680 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
1,403,642 | $104,234,453 |
All Filings in RXRX
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $12,183,019 | 3,968,411 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $14,069,389 | 3,439,949 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $16,286,001 | 3,337,296 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $14,749,250 | 2,914,872 | Shares | Other | 2025-08-13 | |
| 2025-03-31 | $12,670,542 | 2,395,188 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $16,186,892 | 2,394,511 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $13,329,097 | 2,022,625 | Shares | Other | 2024-11-13 | |
| 2024-06-30 | $9,859,574 | 1,314,610 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $12,828,297 | 1,286,690 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $12,774,486 | 1,295,587 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $10,013,329 | 1,308,932 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $9,352,341 | 1,251,987 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $7,709,031 | 1,155,777 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $8,941,308 | 1,159,703 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $12,062,545 | 1,133,698 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $7,987,634 | 981,282 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $6,154,334 | 859,544 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $15,176,510 | 885,961 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $5,767,939 | 250,671 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $8,846,723 | 242,376 | Shares | Defined | 2021-08-13 | |
| No filing history on record for this holder in this stock. | ||||||